Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage

Biochimie

Volumn 93, Issue 2, 2011, Pages 331-338

  Sánchez, Daniel ^a   Moussaoui, Mohammed ^a   Carreras, Esther ^a   Torrent, Marc ^a   Nogués, Victria ^a   Boix, Ester ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Antimicrobial peptides; Chemical cleavage; Eosinophil cationic protein; Host defense; Proteolysis

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DENATURATION;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; CYANOGEN BROMIDE; EOSINOPHIL CATIONIC PROTEIN; ESCHERICHIA COLI; HUMANS; LYSOBACTER; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN DENATURATION; STAPHYLOCOCCUS AUREUS;

EID: 78651308063     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.10.005     Document Type: Article

References (61)

1. E. Boix, M. Torrent, D. Sánchez, and M.V. Nogués The antipathogen activities of eosinophil cationic protein Curr. Pharm. Biotechnol. 9 2008 141 152
2. H.F. Rosenberg Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity J. Biol. Chem. 270 1995 7876 7881
3. E. Carreras, E. Boix, H.F. Rosenberg, C.M. Cuchillo, and M.V. Nogues Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein Biochemistry 42 2003 6636 6644
4. M. Torrent, E. Cuyas, E. Carreras, S. Navarro, O. Lopez, A. de la Maza, M.V. Nogues, Y.K. Reshetnyak, and E. Boix Topography studies on the membrane interaction mechanism of the eosinophil cationic protein Biochemistry 46 2007 720 733
5. M. Torrent, S. Navarro, M. Moussaoui, M.V. Nogues, and E. Boix Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans Biochemistry 47 2008 3544 3555
6. M. Torrent, D. Sánchez, V. Buzón, M.V. Nogués, J. Cladera, and E. Boix Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7 Biochim. Biophys. Acta 1788 2009 1116 1125
7. M. Torrent, M. Badia, M. Moussaoui, D. Sanchez, M.V. Nogues, and E. Boix Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall Febs J. 277 2010 1713 1725
8. E. Guani-Guerra, T. Santos-Mendoza, S.O. Lugo-Reyes, and L.M. Teran Antimicrobial peptides: general overview and clinical implications in human health and disease Clin. Immunol. 135 2010 1 11
9. K. During, P. Porsch, A. Mahn, O. Brinkmann, and W. Gieffers The non-enzymatic microbicidal activity of lysozymes FEBS Lett. 449 1999 93 100
10. L. Otvos Jr. Antibacterial peptides and proteins with multiple cellular targets J. Pept. Sci. 11 2005 697 706
11. P. Nicolas Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides Febs J. 276 2009 6483 6496
12. J.D. Hale, and R.E. Hancock Alternative mechanisms of action of cationic antimicrobial peptides on bacteria Expert Rev. Anti Infect. Ther. 5 2007 951 959
13. R. Dziarski, and D. Gupta Peptidoglycan recognition in innate immunity J. Endotoxin Res. 11 2005 304 310
14. Y. Rosenfeld, and Y. Shai Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis Biochim. Biophys. Acta 1758 2006 1513 1522
15. K. Lohner New strategies for novel antibiotics: peptides targeting bacterial cell membranes Gen. Physiol. Biophys. 28 2009 105 116
16. V.J. Iacono, S.M. Zove, B.L. Grossbard, J.J. Pollock, D.H. Fine, and L.S. Greene Lysozyme-mediated aggregation and lysis of the periodontal microorganism Capnocytophaga gingivalis 2010 Infect. Immun. 47 1985 457 464
17. K. Brandenburg, M.H. Koch, and U. Seydel Biophysical characterisation of lysozyme binding to LPS Re and lipid A Eur. J. Biochem. 258 1998 686 695
18. A. Pellegrini, U. Thomas, R. von Fellenberg, and P. Wild Bactericidal activities of lysozyme and aprotinin against gram-negative and gram-positive bacteria related to their basic character J. Appl. Bacteriol. 72 1992 180 187
19. W.M. Shafer, L.E. Martin, and J.K. Spitznagel Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate Infect. Immun. 45 1984 29 35
20. N.Y. Yount, A.S. Bayer, Y.Q. Xiong, and M.R. Yeaman Advances in antimicrobial peptide immunobiology Biopolymers 84 2006 435 458
21. K.L. Brown, and R.E. Hancock Cationic host defense (antimicrobial) peptides Curr. Opin. Immunol. 18 2006 24 30
22. M.F. Burton, and P.G. Steel The chemistry and biology of LL-37 Nat. Prod. Rep. 26 2009 1572 1584
23. G.H. Gudmundsson, and B. Agerberth Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system J. Immunol. Methods 232 1999 45 54
24. H. Kuwata, T.T. Yip, M. Tomita, and T.W. Hutchens Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin Biochim. Biophys. Acta 1429 1998 129 141
25. P.H. Nibbering, E. Ravensbergen, M.M. Welling, L.A. van Berkel, P.H. van Berkel, E.K. Pauwels, and J.H. Nuijens Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria Infect. Immun. 69 2001 1469 1476
26. O. Levy Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents Blood 96 2000 2664 2672
27. M. Zanetti, R. Gennaro, and D. Romeo Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain FEBS Lett. 374 1995 1 5
28. T. Ayabe, D.P. Satchell, P. Pesendorfer, H. Tanabe, C.L. Wilson, S.J. Hagen, and A.J. Ouellette Activation of Paneth cell alpha-defensins in mouse small intestine J. Biol. Chem. 277 2002 5219 5228
29. H.F. Rosenberg RNase A ribonucleases and host defense: an evolving story J. Leukoc. Biol. 83 2008 1079 1087
30. T. Nitto, K.D. Dyer, M. Czapiga, and H.F. Rosenberg Evolution and function of leukocyte RNase A ribonucleases of the avian species, Gallus gallus J. Biol. Chem. 281 2006 25622 25634
31. E. Pizzo, and G. D'Alessio The success of the RNase scaffold in the advance of biosciences and in evolution Gene 406 2007 8 12
32. M. Torrent, B.G. de la Torre, V.M. Nogues, D. Andreu, and E. Boix Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment Biochem. J. 421 2009 425 434
33. E. Boix, Z. Nikolovski, G.P. Moiseyev, H.F. Rosenberg, C.M. Cuchillo, and M.V. Nogues Kinetic and product distribution analysis of human eosinophil cationic protein indicates a subsite arrangement that favors exonuclease-type activity J. Biol. Chem. 274 1999 15605 15614
34. J. Lacadena, A. Martinez del Pozo, M. Gasset, B. Patino, R. Campos-Olivas, C. Vazquez, A. Martinez-Ruiz, J.M. Mancheno, M. Onaderra, and J.G. Gavilanes Characterization of the antifungal protein secreted by the mould Aspergillus giganteus Arch. Biochem. Biophys. 324 1995 273 281
35. P.A. Jekel, W.J. Weijer, and J.J. Beintema Use of endoproteinase Lys-C from Lysobacter enzymogenes in protein sequence analysis Anal. Biochem. 134 1983 347 354
36. E. Gross, and B. Witkop Nonenzymatic cleavage of peptide bonds: the methionine residues in bovine pancreatic ribonuclease J. Biol. Chem. 237 1962 1856 1860
37. E. Boix, Y. Wu, V.M. Vasandani, S.K. Saxena, W. Ardelt, J. Ladner, and R.J. Youle Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity J. Mol. Biol. 257 1996 992 1007
38. J. Alonso, M.V. Nogues, and C.M. Cuchillo Modification of bovine pancreatic ribonuclease A with 6-chloropurine riboside Arch. Biochem. Biophys. 246 1986 681 689
39. J. Bravo, E. Fernandez, M. Ribo, R. de Llorens, and C.M. Cuchillo A versatile negative-staining ribonuclease zymogram Anal. Biochem. 219 1994 82 86
40. K. Hilpert, R. Volkmer-Engert, T. Walter, and R.E. Hancock High-throughput generation of small antibacterial peptides with improved activity Nat. Biotechnol. 23 2005 1008 1012
41. M.R. Gregory, W.E. Daniel Jr., and R.G. Hiskey Spin-labeled ribonuclease A. Effects of chemical, enzymatic, and physical modifications on enzyme conformation Biochemistry 17 1978 2025 2030
42. B. Gutte, and R.B. Merrifield The total synthesis of an enzyme with ribonuclease A activity J. Am. Chem. Soc. 91 1969 501 502
43. V.G. Janolino, H.E. Swaisgood, and H.R. Horton Renaturation of soluble and immobilized ribonuclease: are the polypeptide folding pathways for structure formation the same for soluble proteins and for proteins associated with a surface? J. Appl. Biochem. 7 1985 33 37
44. Z. Nikolovski, V. Buzon, M. Ribo, M. Moussaoui, M. Vilanova, C.M. Cuchillo, J. Cladera, and M.V. Nogues Thermal unfolding of eosinophil cationic protein/ribonuclease 3: a nonreversible process Protein Sci. 15 2006 2816 2827
45. H.R. Ibrahim, U. Thomas, and A. Pellegrini A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action J. Biol. Chem. 276 2001 43767 43774
46. C. Hoogland, E. Gasteiger, A. Gattiker, S. Duvaud, M.R. Wilkins, R.D. Appel, and A. Bairoch J.o.h.n.M. Walker, Protein Identification and Analysis Tools on the ExPASy Server 2005
47. E. Gasteiger, A. Gattiker, C. Hoogland, I. Ivanyi, R.D. Appel, and A. Bairoch ExPASy: the proteomics server for in-depth protein knowledge and analysis Nucleic Acids Res. 31 2003 3784 3788
48. M. Torrent, V.M. Nogues, and E. Boix A theoretical approach to spot active regions in antimicrobial proteins BMC Bioinformatics 10 2009 373 382
49. J. Zhang, H.F. Rosenberg, and M. Nei Positive Darwinian selection after gene duplication in primate ribonuclease genes Proc. Natl. Acad. Sci. USA 95 1998 3708 3713
50. M. Merrett Primary structure of 3-phosphoglycerate kinase from horse muscle. II. Amino acid sequence of cyanogen bromide peptides CB1-CB4 and CB6-CB14, sequence of methionine-containing regions, and complete sequence of the enzyme J. Biol. Chem. 256 1981 10293 10305
51. H.V. Huang, M.W. Bond, M.W. Hunkapiller, and L.E. Hood Cleavage at tryptophanyl residues with dimethyl sulfoxide-hydrochloric acid and cyanogen bromide Meth. Enzymol. 91 1983 318 324
52. D.W. Boulware, P.D. Goldsworthy, F.A. Nardella, and M. Mannik Cyanogen bromide cleaves Fc fragments of pooled human IgG at both methionine and tryptophan residues Mol. Immunol. 22 1985 1317 1322
53. B.J. Smith J.M. Walker, Chemical Cleavage of Proteins at Tryptophan Residues 1996 Human Press Inc. Totowa, NJ
54. E. Carreras, E. Boix, S. Navarro, H.F. Rosenberg, C.M. Cuchillo, and M.V. Nogues Surface-exposed amino acids of eosinophil cationic protein play a critical role in the inhibition of mammalian cell proliferation Mol. Cell. Biochem. 272 2005 1 7
55. T.C. Fan, S.L. Fang, C.S. Hwang, C.Y. Hsu, X.A. Lu, S.C. Hung, S.C. Lin, and D.T. Chang Characterization of molecular interactions between eosinophil cationic protein and heparin J. Biol. Chem. 283 2008 25468 25474
56. M. Torrent, M.V. Nogues, and E. Boix Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site J. Mol. Recognit. 2010
57. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 2002 389 395
58. D. Andreu, and L. Rivas Animal antimicrobial peptides: an overview Biopolymers 47 1998 415 433
59. M.F. García-Mayoral, M. Moussaoui, B.G. de la Torre, D. Andreu, E. Boix, M.V. Nogués, M. Rico, D.V. Laurents, and M. Bruix NMR structural determinants of eosinophil cationic protein binding to membrane and heparin mimetics Biophys. J. 98 2010 2702 2711
60. M. Torrent, F. Odorizzi, M.V. Nogués, and E. Boix Eosinophil cationic protein (ECP) aggregation. Identification of an N-terminus amyloid prone region Biomacromolecules 11 2010 1983 1990
61. E. Boix, D.D. Leonidas, Z. Nikolovski, M.V. Nogues, C.M. Cuchillo, and K.R. Acharya Crystal structure of eosinophil cationic protein at 2.4 A resolution Biochemistry 38 1999 16794 16801